What is MDAI's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.05B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for MDAI?

P/E (TTM) is n/a and 52-week range is $1.18 to $2.97 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s MDAI figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for MDAI?

The company profile lists revenue (TTM) near $15M, net income (TTM) near $-1.00B, EPS (TTM) near $-0.34 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Spectral AI Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Dallas, Texas, US, 31.8M shares outstanding, ISIN US84757T1051 when available from company profile and filing metadata.

Spectral AI Inc

$MDAI

Health Care · Health Care Equipment & Supplies

Run Scenarios

$1.65

+0.61%

Spectral AI Inc

$MDAI

Health Care · Health Care Equipment & Supplies

Run Scenarios

$1.65

+0.61%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Spectral AI, Inc. is a predictive artificial intelligence company. The company is headquartered in Dallas, Texas and currently employs 65 full-time employees. The company went IPO on 2021-02-12. The firm's DeepView platform is a predictive device that offers clinicians an objective and immediate assessment of a wound healing potential prior to treatment or other medical intervention. DeepView platform that combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential. The company is non-invasive, non-radiation, non-laser and does not require the use of injectable dye. The DeepView AI- Burn software is used with the DeepView SnapShot imaging device, and it is intended to be used as an adjunctive tool to aid healthcare providers in the assessment of burn wound healing potential by differentiating non-healing from healing burned tissue within an image.

Employees

65

Website

www.spectral-ai.com/

IPO

2021-02-12

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)

EPS (TTM)

P/E (TTM)

P/S (TTM)

Forward P/E

Forward P/S

EV / EBITDA

PEG (TTM)

FCF yield (TTM)

Gross margin (TTM)

Net margin (TTM)

Forward revenue growth (NTM)

Dividend / share (TTM)

Dividend yield (TTM)

Payout ratio (TTM)

Dividend growth (5Y)

Company context

Exchange

NASDAQ NMS - GLOBAL MARKET

ISIN

US84757T1051

Headquarters

Dallas, Texas, US

Shares outstanding

31.8M

NAICS sector

Information

Institutional ownership

16.80%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Spectral AI, Inc. is a predictive artificial intelligence company. The company is headquartered in Dallas, Texas and currently employs 65 full-time employees. The company went IPO on 2021-02-12. The firm's DeepView platform is a predictive device that offers clinicians an objective and immediate assessment of a wound healing potential prior to treatment or other medical intervention. DeepView platform that combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential. The company is non-invasive, non-radiation, non-laser and does not require the use of injectable dye. The DeepView AI- Burn software is used with the DeepView SnapShot imaging device, and it is intended to be used as an adjunctive tool to aid healthcare providers in the assessment of burn wound healing potential by differentiating non-healing from healing burned tissue within an image.

Employees

65

Website

www.spectral-ai.com/

IPO

2021-02-12

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)